Metabolic syndrome predicts hospitalization in hemodialysis patients: A prospective asian cohort study

Blood Purification

Volumn 25, Issue 3, 2007, Pages 252-259

  Yang, Shao Yu ^a,b   Chiang, Chih Kang ^b   Hsu, Shih Ping ^a   Peng, Yu Sen ^a   Pai, Mei Fen ^a   Ho, Tai I ^a   Hung, Kuan Yu ^b   Wu, Kwan Dun ^b  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Hemodialysis; Hospitalization risk, metabolic syndrome; Metabolic syndrome, Asian criteria

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CALCIUM; CHOLESTEROL; CREATININE; FERRITIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITROGEN; PHOSPHATE; POTASSIUM; SODIUM; TRIACYLGLYCEROL; UREA; URIC ACID;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHOSPHATE BLOOD LEVEL; POPULATION RISK; POTASSIUM BLOOD LEVEL; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; SODIUM BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; INFECTION; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK; SURVIVAL ANALYSIS; TAIWAN;

EID: 34447550651     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101698     Document Type: Article

References (26)

1. Reaven GM: Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
2. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689.
3. Lakka HM, Lakksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-age men. JAMA 2002;288:2709-2716.
4. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR: Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110,1245-1250.
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
6. Lin WY, Lee LT, Chen CY, Lo H, Hsia HH, Liu IL, Lin RS, Shau WY, Huang KC: Optimal cut-off values for obesity: using simple anthropometric indices to predict cardiovascular risk factors in Taiwan. Int J Obes Relat Metab Disord 2002;26:1232-1238.
7. Tan CE, Ma S, Wai D, Chew SK, Tai ES: Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004;27:1184-1186.
8. WHO/IASO/IOTF: The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Sydney, World Health Organization, Western Pacific Region, 2000.
9. Heng D, Ma S, Lee JJM, Tai BC, Mak KH, Hughes K, Chew SK, Chia KS, Tan CE, Tai ES: Modification of the NCEP ATP III definitions of the metabolic syndrome for use in Asians identifies individuals at risk of ischemic heart disease. Atherosclerosis 2006;186:367-373.
10. Oh JY, Sung YA, Hong YS, Barrett-Connor E: Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Diabetes Care 2004;27:2027-2032.
11. Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697-701.
12. Iseki K, Yamazato M, Tozawa M, Takishita S: Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. Kidney Int 2002;61:1887-1893.
13. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH: A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 2001;38:1251-1263.
14. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, Van Stone J, Levey A, Meyer KB, Klag MJ, Johnson HK, Clark E, Sadler JH, Teredesai P: 'U' curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 1998;54:561-569.
15. Port FK, Hulbert-Shearon TE, Wolfe RA, Bloembergen WE, Golper TA, Agodoa LY, Young EW: Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 1999;33:507-517.
16. Leavey SF, Strawderman RL, Jones CA, Port FK, Held PJ: Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis 1998;31:997-1006.
17. Fleischmann E, Teal N, Dudley J, May W, Bower JD, Salahudeen AK: Influence of excess weight on mortality and hospital stay in 1,346 hemodialysis patients. Kidney Int 1999;55:1560-1567.
18. Chiang CK, Hsu SP, Pai MF, Peng YS, Ho TI, Liu SH, Hung KY, Tsai TJ: Interleukin-18 is a strong indicator of hospitalization in hemodialysis patients. Nephrol Dial Transplant 2004;19:2810-2815.
19. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD: Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003;63:793-808.
20. Wong JS, Port FK, Hulbert-Shearon TE, Carroll CE, Wolfe RA, Agodoa LYC, Daugirdas JT: Survival advantage in Asian American end-stage renal disease patients. Kidney Int 1999;55:2515-2523.
21. International Diabetes Federation: The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org/webdata/docs/Metac_syndrome_def. pdf, 2005.
22. Daugirdas JT: The post: pre-dialysis plasma urea nitrogen ratio to estimate Kt/V and NPCR: mathematical modeling. Int J Artif Organs 1989;12:411-419.
23. Hakim RM, Depner TA, Parker TF 3rd: Adequacy of hemodialysis. Am J Kidney Dis 1992;20:107-123.
24. Chiang CK, Ho TI, Hsu SP, Peng YS, Pai MF, Yang SY, Hung KY, Tsai TJ: Low-density lipoprotein cholesterol: association with mortality and hospitalization in hemodialysis patients. Blood Purif 2005;23:134-140.
25. Nishizawa Y, Shoji T, Emoto M, Koyama H, Tahara H, Fukumoto S, Inaba M, Ishimura E, Miki T: Roles of metabolic and endocrinological alterations in atherosclerosis and cardiovascular disease in renal failure: another form of metabolic syndrome. Semin Nephrol 2004;24:423-425.
26. Patient Registration Committee, Japanese Society for Dialysis Therapy: An overview of regular dialysis treatment in Japan as of 31 December 2003. Ther Apher Dial 2005;9:431-458.